ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Total assets

ABBOTT LABORATORIES (ABT)

Market cap
$165.9B
P/E ratio
25.7x
SummaryFinancials
Period EndTotal assets (Million USD)YoY (%)
Dec 31, 202586,713+6.51%
Dec 31, 202481,414+11.20%
Dec 31, 202373,214-1.64%
Dec 31, 202274,438-1.01%
Dec 31, 202175,196+3.65%
Dec 31, 202072,548+6.87%
Dec 31, 201967,887+1.06%
Dec 31, 201867,173-11.90%
Dec 31, 201776,250+44.78%
Dec 31, 201652,666+27.68%
Dec 31, 201541,247-3.97%
Dec 31, 201342,953-28.74%
Dec 31, 201160,277+1.37%
Dec 31, 201059,462

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat